{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:57Z","timestamp":1792783077545,"version":"4.5.0"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ain Shams University","id":[{"id":"https:\/\/ror.org\/00cb9w016","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammation is a central driver of neurodegeneration in Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), driven by interconnected pathways involving microglial state dysregulation, inflammasome activation, cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS\u2013STING) signaling, impaired mitophagy, CD33-TREM2 imbalance, gut-brain axis disruption, and peripheral immune infiltration across a compromised blood\u2013brain barrier (BBB). Conventional anti-inflammatory therapies remain limited by poor CNS delivery, inadequate cell specificity, and the inability to simultaneously modulate multiple inflammatory pathways. Nano-immunomodulators (NIMs) have emerged as a promising strategy to modulate CNS immunity in preclinical models. This review critically evaluates recent advances in NIM-based strategies for AD and PD, including intrinsically therapeutic nanomaterials, targeted delivery systems, and precision gene-regulatory platforms. Intrinsically therapeutic materials, such as polydopamine nanoparticles and biomimetic nanozymes, provide antioxidant and mitochondrial protective functions, whereas BBB-targeted systems, including nanobody-based platforms and engineered exosomes, enhance targeted CNS delivery. Nanotheranostics approaches integrate imaging capabilities with stimuli-responsive release, while precision interceptors aim to simultaneous regulate pathological processes such as amyloid-beta (A\u03b2)-associated inflammation and cGAS-STING activation. Emerging gene-delivery strategies, including TREM2 mRNA and CD33-targeting lipid nanoparticles, offer opportunities for microglial reprogramming but remain largely restricted to proof-of-concept and early preclinical stages. The review further discusses AI-driven nanomedicine optimization and advanced human-relevant models, including brain-on-a-chip systems and three-dimensional (3D) bioprinting, as tools to improve translational prediction. Currently, AI approaches primarily support candidate selection, formulation optimization, and mechanistic prediction rather than clinical validation. Major challenges for clinical advancement include achieving precise modulation of microglial states beyond the simplified M1\/M2 framework, developing context-dependent regulation of NLRP3 and cGAS\u2013STING pathways, establishing gut\u2013CNS therapeutic strategies, improving pluripotent stem cell (iPSC)-based validation platforms, and defining long-term CNS safety frameworks. By integrating molecular mechanisms, AI-assisted nanomedicine, nanoparticle-enabled immune and gene modulation, and advanced preclinical models, this review provides a mechanistic and translational framework for advancing next-generation NIM strategies in AD and PD. This integrated perspective addresses the limitations of previous single-domain analyses focused either on neuroinflammation or nanotechnology and outlines key considerations for translating NIMs from experimental platforms toward clinical applications.<\/jats:p>","DOI":"10.1007\/s10787-026-02386-0","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:47:37Z","timestamp":1789454857000},"page":"6451-6485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5180-2212","authenticated-orcid":false,"given":"Mohammed A.","family":"Abdel-Rasol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"1","key":"2386_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08186-8","volume":"17","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, Bahijri S, Tuomilehto J, Borai A, Pratico D (2026b) Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay. Cell Death Dis 17(1):21. https:\/\/doi.org\/10.1038\/s41419-025-08186-8","journal-title":"Cell Death Dis"},{"key":"2386_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03505-7","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Alasiri G, Kim B, Khan J, Ajoolabady A, Yousof SM, Ren J, Tuomilehto J, Borai A, Alrfaei BM, Pratico D (2026a) TREM2 in neurodegeneration and diseases. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-026-03505-7","journal-title":"Mol Psychiatry"},{"key":"2386_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632687","volume":"12","author":"C Ackaert","year":"2021","unstructured":"Ackaert C, Smiejkowska N, Xavier C, Sterckx YG, Denies S, Stijlemans B, Elkrim Y, Devoogdt N, Caveliers V, Lahoutte T, Muyldermans S (2021) Immunogenicity risk profile of nanobodies. Front Immunol 12:632687. https:\/\/doi.org\/10.3389\/fimmu.2021.632687","journal-title":"Front Immunol"},{"key":"2386_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987","journal-title":"Front Aging Neurosci"},{"key":"2386_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202504508","author":"ED Aiyegbusi","year":"2026","unstructured":"Aiyegbusi ED, Di Stefano J, Dooley D (2026) Advanced 3D platforms for modeling CNS neuroinflammation: cell integration, techniques, and challenges. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202504508","journal-title":"Adv Healthc Mater"},{"key":"2386_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107133","author":"A Ajoolabady","year":"2025","unstructured":"Ajoolabady A, Kim B, Abdulkhaliq AA, Ren J, Bahijri S, Tuomilehto J, Borai A, Khan J, Pratico D (2025) Dual role of microglia in neuroinflammation and neurodegenerative diseases. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2025.107133","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2386_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40035-025-00513-5","volume":"14","author":"S Amniouel","year":"2025","unstructured":"Amniouel S, Suh J, Zheng W, Zhang Q (2025) Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer\u2019s disease. Transl Neurodegener 14(1):51. https:\/\/doi.org\/10.1186\/s40035-025-00513-5","journal-title":"Transl Neurodegener"},{"key":"2386_CR8","doi-asserted-by":"publisher","first-page":"1708655","DOI":"10.3389\/fneur.2025.1708655","volume":"16","author":"W An","year":"2025","unstructured":"An W, Jin Z, Li Y (2025) Dual role of exosomes in neurodegenerative diseases: a molecular bridge between neuroinflammation and transmission of pathological proteins. Front Neurol 16:1708655. https:\/\/doi.org\/10.3389\/fneur.2025.1708655","journal-title":"Front Neurol"},{"issue":"8","key":"2386_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cimb48080808","volume":"48","author":"EG Andreadou","year":"2026","unstructured":"Andreadou EG, Evangelopoulou E, Tsolaki M, Tsamesidis I, Pessach I, Mitka S (2026) Exosome-based therapeutics in Alzheimer\u2019s disease: translational perspectives beyond conventional therapies. Curr Issues Mol Biol 48(8):808. https:\/\/doi.org\/10.3390\/cimb48080808","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"2386_CR10","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1021\/acsomega.5c10397","volume":"11","author":"AB De Araujo","year":"2026","unstructured":"De Araujo AB, Azul S, F.V., Carneiro, Y.C., De Sousa, C.N., de Vasconcelos, S.M., Rios, F.J. and Leal, L.K. (2026) Neuroinflammation and oxidative stress in parkinson\u2019s disease, alzheimer\u2019s disease, and COVID-19: microglia-neutrophil Interaction. ACS Omega 11(5):6922\u20136938","journal-title":"ACS Omega"},{"key":"2386_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113595","volume":"381","author":"H Baghirov","year":"2025","unstructured":"Baghirov H (2025) Mechanisms of receptor-mediated transcytosis at the blood-brain barrier. J Control Release 381:113595. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113595","journal-title":"J Control Release"},{"issue":"8","key":"2386_CR12","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1021\/acs.molpharmaceut.5c00385","volume":"22","author":"Y Bai","year":"2025","unstructured":"Bai Y, Cui L, Liu T, Wang Z, Cao H, He S, Qiu J, Li Y, Zhou Y, Shi J, Wang J (2025) Recent advances in mRNA-LNP delivery systems for extrahepatic organs: a review. Mol Pharm 22(8):4474\u20134493. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00385","journal-title":"Mol Pharm"},{"key":"2386_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119292","volume":"217","author":"WC Ballance","year":"2019","unstructured":"Ballance WC, Qin EC, Chung HJ, Gillette MU, Kong H (2019) Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials 217:119292. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119292","journal-title":"Biomaterials"},{"issue":"22","key":"2386_CR14","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1021\/acschemneuro.5c00649","volume":"16","author":"A Bansal","year":"2025","unstructured":"Bansal A, Sharma AR, Chakraborty A, Sunkaria A, Jain A (2025) Machine learning-based bioactivity prediction and descriptor-guided rational design of amyloid-\u03b2 aggregation inhibitors. ACS Chem Neurosci 16(22):4351\u20134363. https:\/\/doi.org\/10.1021\/acschemneuro.5c00649","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"2386_CR15","doi-asserted-by":"publisher","first-page":"10485","DOI":"10.1021\/acsami.4c21207","volume":"17","author":"M Battaglini","year":"2025","unstructured":"Battaglini M, Carmignani A, Ciobanu DZ, Marino A, Catalano F, Armirotti A, Ciofani G (2025) Detailed profiling of protein corona formed by polydopamine nanoparticles in human plasma. ACS Appl Mater Interfaces 17(7):10485\u201310498. https:\/\/doi.org\/10.1021\/acsami.4c21207","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"2386_CR16","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/ijms26062440","volume":"26","author":"AI Beltran-Velasco","year":"2025","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ (2025) Impact of peripheral inflammation on blood\u2013brain barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci 26(6):2440. https:\/\/doi.org\/10.3390\/ijms26062440","journal-title":"Int J Mol Sci"},{"issue":"10291","key":"2386_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"6","key":"2386_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1039\/d5pm00204d","volume":"2","author":"RJ Boado","year":"2025","unstructured":"Boado RJ (2025) Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood\u2013brain barrier. RSC Pharmaceutics 2(6):1349\u20131375. https:\/\/doi.org\/10.1039\/d5pm00204d","journal-title":"RSC Pharmaceutics"},{"issue":"2","key":"2386_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","volume":"112","author":"MJL Bours","year":"2006","unstructured":"Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5\u2032-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112(2):358\u2013404. https:\/\/doi.org\/10.1016\/j.pharmthera.2005.04.013","journal-title":"Pharmacol Ther"},{"key":"2386_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00282","volume":"13","author":"LS Brown","year":"2019","unstructured":"Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA (2019) Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci 13:282. https:\/\/doi.org\/10.3389\/fncel.2019.00282","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"2386_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM (2016) Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 16(7):407\u2013420. https:\/\/doi.org\/10.1038\/nri.2016.58","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2386_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/NRR.NRR-D-24-00917","volume":"21","author":"X Cai","year":"2026","unstructured":"Cai X, Cai X, Xie Q, Xiao X, Li T, Zhou T, Sun H (2026) NLRP3 inflammasome and gut microbiota\u2013brain axis: a new perspective on white matter injury after intracerebral hemorrhage. Neural Regen Res 21(1):62\u201380. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00917","journal-title":"Neural Regen Res"},{"issue":"14","key":"2386_CR23","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2174\/1381612824666180403113015","volume":"24","author":"MD Cayero-Otero","year":"2018","unstructured":"Cayero-Otero MD, Espinosa-Oliva AM, Herrera AJ, Garcia-Dominguez I, Fernandez-Arevalo M, Martin-Banderas L, de Pablos RM (2018) Potential use of nanomedicine for the anti-inflammatory treatment of neurodegenerative diseases. Curr Pharm des 24(14):1589\u20131616. https:\/\/doi.org\/10.2174\/1381612824666180403113015","journal-title":"Curr Pharm des"},{"key":"2386_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1672520","volume":"13","author":"MC Ceccarelli","year":"2025","unstructured":"Ceccarelli MC, Lai L, Carmignani A, Battaglini M, Ciofani G (2025) Polydopamine nanoparticles as immunomodulators: inhibition of M1 microglial polarization. Front Bioeng Biotechnol 13:p.1672520. https:\/\/doi.org\/10.3389\/fbioe.2025.1672520","journal-title":"Front Bioeng Biotechnol"},{"issue":"13","key":"2386_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","volume":"13","author":"V Ce\u00f1a","year":"2018","unstructured":"Ce\u00f1a V, J\u00e1tiva P (2018) Nanoparticle crossing of blood\u2013brain barrier: a road to new therapeutic approaches to central nervous system diseases. Nanomedicine (Lond) 13(13):1513\u20131516. https:\/\/doi.org\/10.2217\/nnm-2018-0139","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"2386_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14218\/JTG.2025.00027","volume":"3","author":"SK Chakrabarti","year":"2025","unstructured":"Chakrabarti SK, Chattopadhyay D (2025) The gut\u2013brain\u2013immune triad in neurodegeneration: an integrated perspective. J Transl Gastroenterol 3(3):136\u2013154. https:\/\/doi.org\/10.14218\/JTG.2025.00027","journal-title":"J Transl Gastroenterol"},{"key":"2386_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200527","author":"Y Che","year":"2026","unstructured":"Che Y, Yu Z, Ji S, Yang D (2026) Decoding TREM2 signaling pathways: linking macrophage glycolysis to inflammatory diseases in the CNS. Neurol: Neuroimmunol Neuroinflammat. https:\/\/doi.org\/10.1212\/NXI.0000000000200527","journal-title":"Neurol: Neuroimmunol Neuroinflammat"},{"issue":"7953","key":"2386_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, Shchukina I (2023) Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615(7953):668\u2013677. https:\/\/doi.org\/10.1038\/s41586-023-05788-0","journal-title":"Nature"},{"issue":"1","key":"2386_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","volume":"6","author":"C Chen","year":"2025","unstructured":"Chen C, Wang GQ, Li DD, Zhang F (2025) Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Molecular Biomedicine 6(1):64. https:\/\/doi.org\/10.1186\/s43556-025-00307-1","journal-title":"Molecular Biomedicine"},{"key":"2386_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2026.173836","author":"X Chen","year":"2026","unstructured":"Chen X, Zhan Y, Fan X, Pan J, Wang W, Jiang W, Liu Y, Tang J (2026) Nanozymes for inflammatory disease therapy: ROS homeostasis and clinical prospects. Chem Eng J. https:\/\/doi.org\/10.1016\/j.cej.2026.173836","journal-title":"Chem Eng J"},{"issue":"1","key":"2386_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12645-012-0029-9","volume":"3","author":"MR Choi","year":"2012","unstructured":"Choi MR, Bardhan R, Stanton-Maxey KJ, Badve S, Nakshatri H, Stantz KM, Cao N, Halas NJ, Clare SE (2012) Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol 3(1):47\u201354. https:\/\/doi.org\/10.1007\/s12645-012-0029-9","journal-title":"Cancer Nanotechnol"},{"issue":"9","key":"2386_CR32","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong JH, Park JC, Han JW, Lee Y, Kim JI, Mook-Jung I (2024) Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Exp Mol Med (Seoul) 56(9):1936\u20131951. https:\/\/doi.org\/10.1038\/s12276-024-01295-y","journal-title":"Exp Mol Med (Seoul)"},{"issue":"1","key":"2386_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, De Bernard M (2013) Triggering of inflammasome by aggregated \u03b1\u2013synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8(1):e55375. https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS ONE"},{"issue":"3","key":"2386_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248\u2013255. https:\/\/doi.org\/10.1038\/nm.3806","journal-title":"Nat Med"},{"issue":"1","key":"2386_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1665","volume":"13","author":"RM Crist","year":"2021","unstructured":"Crist RM, Dasa SSK, Liu CH, Clogston JD, Dobrovolskaia MA, Stern ST (2021) Challenges in the development of nanoparticle\u2010based imaging agents: characterization and biology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 13(1):p.e1665. https:\/\/doi.org\/10.1002\/wnan.1665","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"10","key":"2386_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102793","volume":"11","author":"F De Marchi","year":"2023","unstructured":"De Marchi F, Munitic I, Vidatic L, Papi\u0107 E, Ra\u010dki V, Nimac J, Jurak I, Novotni G, Rogelj B, Vuletic V, Liscic RM (2023) Overlapping neuroimmune mechanisms and therapeutic targets in neurodegenerative disorders. Biomedicines 11(10):2793. https:\/\/doi.org\/10.3390\/biomedicines11102793","journal-title":"Biomedicines"},{"issue":"8","key":"2386_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/13543784.2023.2249814","volume":"32","author":"T De Pauw","year":"2023","unstructured":"De Pauw T, De Mey L, Debacker JM, Raes G, Van Ginderachter JA, De Groof TW, Devoogdt N (2023) Current status and future expectations of nanobodies in oncology trials. Expert Opin Investig Drugs 32(8):705\u2013721. https:\/\/doi.org\/10.1080\/13543784.2023.2249814","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"2386_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2386_CR39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181(6):1207\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2020.05.003","journal-title":"Cell"},{"issue":"1","key":"2386_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","volume":"46","author":"B D\u00edaz-Castro","year":"2023","unstructured":"D\u00edaz-Castro B, Robel S, Mishra A (2023) Astrocyte endfeet in brain function and pathology: open questions. Annu Rev Neurosci 46(1):101\u2013121. https:\/\/doi.org\/10.1146\/annurev-neuro-091922-031205","journal-title":"Annu Rev Neurosci"},{"issue":"7610","key":"2386_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535(7610):111\u2013116. https:\/\/doi.org\/10.1038\/nature18590","journal-title":"Nature"},{"key":"2386_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1599340","volume":"12","author":"P Dipankar","year":"2025","unstructured":"Dipankar P, Salazar D, Dennard E, Mohiyuddin S, Nguyen QC (2025) Artificial intelligence based advancements in nanomedicine for brain disorder management: an updated narrative review. Front Med 12:1599340. https:\/\/doi.org\/10.3389\/fmed.2025.1599340","journal-title":"Front Med"},{"issue":"12","key":"2386_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17120197","volume":"17","author":"JM Dong","year":"2025","unstructured":"Dong JM, Zhong H (2025) Systematic review: proteomics-driven multi-omics integration for Alzheimer\u2019s disease pathology and precision medicine. Neurol Int 17(12):197. https:\/\/doi.org\/10.3390\/neurolint17120197","journal-title":"Neurol Int"},{"issue":"4","key":"2386_CR44","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10072-024-07871-4","volume":"46","author":"N Dong","year":"2025","unstructured":"Dong N, Ali-Khiavi P, Ghavamikia N, Pakmehr S, Sotoudegan F, Hjazi A, Gargari MK, Gargari HK, Behnamrad P, Rajabi M, Elhami A (2025) Nanomedicine in the treatment of Alzheimer\u2019s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology. Neurol Sci 46(4):1489\u20131507. https:\/\/doi.org\/10.1007\/s10072-024-07871-4","journal-title":"Neurol Sci"},{"issue":"3","key":"2386_CR45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, Carreira B, Pozzi S, Ac\u00farcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ (2022) Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 12(3):500\u2013525. https:\/\/doi.org\/10.1007\/s13346-021-01024-2","journal-title":"Drug Deliv Transl Res"},{"issue":"12","key":"2386_CR46","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.4103\/1673-5374.373673","volume":"18","author":"JCC Dos Santos","year":"2023","unstructured":"Dos Santos JCC, Oliveira LF, Noleto FM, Gusm\u00e3o CTP, de Castro Brito GA, de Barros Viana GS (2023) Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson\u2019s disease. Neural Regen Res 18(12):2611\u20132614. https:\/\/doi.org\/10.4103\/1673-5374.373673","journal-title":"Neural Regen Res"},{"key":"2386_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202519340","author":"Z Duan","year":"2026","unstructured":"Duan Z, Li P, Wang Y, Qi X, Wang W, Cheng Y, Zhang H, Hu X, Gao X (2026) Biomimetic Ru\u2010Mn nanozyme with cascade catalytic activity attenuates secondary brain injury in intracerebral hemorrhage. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202519340","journal-title":"Adv Sci"},{"issue":"8","key":"2386_CR48","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.3390\/ijms26083522","volume":"26","author":"C Du\u021b\u0103","year":"2025","unstructured":"Du\u021b\u0103 C, Dogaru CB, Muscurel C, Stoian I (2025) Nanozymes: innovative therapeutics in the battle against neurodegenerative diseases. Int J Mol Sci 26(8):3522. https:\/\/doi.org\/10.3390\/ijms26083522","journal-title":"Int J Mol Sci"},{"key":"2386_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101111","volume":"90","author":"G Eskandari-Sedighi","year":"2023","unstructured":"Eskandari-Sedighi G, Jung J, Macauley MS (2023) CD33 isoforms in microglia and Alzheimer\u2019s disease: friend and foe. Mol Aspects Med 90:101111. https:\/\/doi.org\/10.1016\/j.mam.2022.101111","journal-title":"Mol Aspects Med"},{"issue":"1","key":"2386_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-023-00462-z","volume":"20","author":"TJ Esparza","year":"2023","unstructured":"Esparza TJ, Su S, Francescutti CM, Rodionova E, Kim JH, Brody DL (2023) Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody. Fluids Barriers CNS 20(1):p.64. https:\/\/doi.org\/10.1186\/s12987-023-00462-z","journal-title":"Fluids Barriers CNS"},{"key":"2386_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1474012","volume":"16","author":"A \u00c9vora","year":"2025","unstructured":"\u00c9vora A, Garcia G, Rubi A, De Vitis E, Matos AT, Vaz AR, Gervaso F, Gigli G, Polini A, Brites D (2025) Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron\u2013glia crosstalk in Alzheimer\u2019s disease. Front Pharmacol 16:1474012. https:\/\/doi.org\/10.3389\/fphar.2025.1474012","journal-title":"Front Pharmacol"},{"key":"2386_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07604-x","author":"AF Feiten","year":"2026","unstructured":"Feiten AF, Dahm K, Schlepckow K, van Lengerich B, Suh JH, Reifschneider A, Wefers B, Bartos LM, Wind-Mark K, de Weerd L, Ulas T (2026) TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism. Nat Commun. https:\/\/doi.org\/10.1186\/s12967-025-07604-x","journal-title":"Nat Commun"},{"issue":"1","key":"2386_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/17590914.2025.2465546","volume":"17","author":"G Feng","year":"2025","unstructured":"Feng G, Lan X, Qin S, Shi Y, Zhao Q, Li Q, Zhong L (2025) Advances in research on exosomal miRNAs in central nervous system diseases. ASN Neuro 17(1):2465546. https:\/\/doi.org\/10.1080\/17590914.2025.2465546","journal-title":"ASN Neuro"},{"issue":"19","key":"2386_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199478","volume":"26","author":"I Ferrari","year":"2025","unstructured":"Ferrari I, Limiti E, Giannitelli SM, Trombetta M, Rainer A, D\u2019Amelio M, La Barbera L, Gori M (2025) Microfluidic-based technologies for crossing the blood\u2013brain barrier against Alzheimer\u2019s disease: novel strategies and challenges. Int J Mol Sci 26(19):9478. https:\/\/doi.org\/10.3390\/ijms26199478","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2386_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"BS Franklin","year":"2014","unstructured":"Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, Brenker C, Nordhoff M, Mirandola SR, Al-Amoudi A, Mangan MS (2014) The adaptor ASC has extracellular and \u201cprionoid\u201d activities that propagate inflammation. Nat Immunol 15(8):727\u2013737. https:\/\/doi.org\/10.1038\/ni.2913","journal-title":"Nat Immunol"},{"issue":"3","key":"2386_CR56","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee SH, Haddick PC, Ngu H, Modrusan Z (2018) Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep 22(3):832\u2013847. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.066","journal-title":"Cell Rep"},{"issue":"11","key":"2386_CR57","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I (2021) The blood\u2013brain barrier in systemic infection and inflammation. Cell Mol Immunol 18(11):2489\u20132501. https:\/\/doi.org\/10.1038\/s41423-021-00757-x","journal-title":"Cell Mol Immunol"},{"key":"2386_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08424-7","author":"Q Gan","year":"2026","unstructured":"Gan Q, Fu X, Zhou T, Fan N, Nan N, Wang Y, Yang Y, Gou S, Hu L, Zhou S (2026) Mitochondrial DNA drives NLRP3-IL-1\u03b2 axis activation in microglia by binding to NLRP3, leading to neurodegeneration in Parkinson\u2019s disease models. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-026-08424-7","journal-title":"Cell Death Dis"},{"issue":"1","key":"2386_CR59","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.1629","volume":"17","author":"R Gao","year":"2025","unstructured":"Gao R, Gao Y, Su W, Wang R (2025a) Decoding microglial polarization and metabolic reprogramming in neurodegenerative diseases: implications for disease progression and therapy. Aging Dis 17(1):91. https:\/\/doi.org\/10.14336\/AD.2024.1629","journal-title":"Aging Dis"},{"issue":"1","key":"2386_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-025-04361-0","volume":"20","author":"X Gao","year":"2025","unstructured":"Gao X, Yang K, Yuan X, Song M, Wang T, Shen C (2025b) Research progress of exosomes used in the Alzheimer\u2019s disease treatment. Discover Nano 20(1):173. https:\/\/doi.org\/10.1186\/s11671-025-04361-0","journal-title":"Discover Nano"},{"key":"2386_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.143350","volume":"467","author":"G Gkogkos","year":"2023","unstructured":"Gkogkos G, Panariello L, Grammenou E, Cornwell MA, Afrashtehpour A, MacRobert AJ, Parkin IP, Gavriilidis A (2023) Synthesis of PEG-PPG-PEG templated polydopamine nanoparticles under intensified conditions: kinetics investigation, continuous process design and demonstration for photothermal application. Chem Eng J 467:143350. https:\/\/doi.org\/10.1016\/j.cej.2023.143350","journal-title":"Chem Eng J"},{"issue":"1","key":"2386_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/antib15010001","volume":"15","author":"D Godugu","year":"2025","unstructured":"Godugu D, Gattu K, Suri P, Daartey AB, Jadhav K, Rojekar S (2025) Nanobody therapeutics in Alzheimer\u2019s disease: from molecular mechanisms to translational approaches. Antibodies (Basel) 15(1):p.1. https:\/\/doi.org\/10.3390\/antib15010001","journal-title":"Antibodies (Basel)"},{"issue":"6","key":"2386_CR63","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/21691401.2017.1313268","volume":"45","author":"J Golchin","year":"2017","unstructured":"Golchin J, Golchin K, Alidadian N, Ghaderi S, Eslamkhah S, Eslamkhah M, Akbarzadeh A (2017) Nanozyme applications in biology and medicine: an overview. Artif Cells Nanomed Biotechnol (Phila) 45(6):1069\u20131076. https:\/\/doi.org\/10.1080\/21691401.2017.1313268","journal-title":"Artif Cells Nanomed Biotechnol (Phila)"},{"issue":"1","key":"2386_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5582\/bst.2023.01288","volume":"18","author":"X Gu","year":"2024","unstructured":"Gu X, Qi L, Qi Q, Zhou J, Chen S, Wang L (2024) Monoclonal antibody therapy for Alzheimer\u2019s disease focusing on intracerebral targets. Biosci Trends 18(1):49\u201365. https:\/\/doi.org\/10.5582\/bst.2023.01288","journal-title":"Biosci Trends"},{"key":"2386_CR65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuroscience.2024.02.014","volume":"544","author":"H Guo","year":"2024","unstructured":"Guo H, Du M, Yang Y, Lin X, Wang Y, Li H, Ren J, Xu W, Yan J, Wang N (2024a) Sp1 regulates the M1 polarization of microglia through the HuR\/NF-\u03baB axis after spinal cord injury. Neuroscience 544:50\u201363. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.02.014","journal-title":"Neuroscience"},{"issue":"52","key":"2386_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202403980","volume":"20","author":"Q Guo","year":"2024","unstructured":"Guo Q, Wang T, Qian C, Wang X (2024b) Redox oxygen species\u2010responsive nanotheranostics with dual\u2010channel fluorescent turn\u2010on for early diagnosis and targeted therapy of Alzheimer\u2019s disease. Small 20(52):p.2403980. https:\/\/doi.org\/10.1002\/smll.202403980","journal-title":"Small"},{"issue":"8","key":"2386_CR67","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat Immunol 9(8):857\u2013865. https:\/\/doi.org\/10.1038\/ni.1636","journal-title":"Nat Immunol"},{"issue":"1","key":"2386_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh J, Marsh SE (2019) Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50(1):253\u2013271. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.004","journal-title":"Immunity"},{"issue":"2","key":"2386_CR69","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","volume":"25","author":"EL Han","year":"2024","unstructured":"Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, Mrksich K, Padilla MS, Palanki R, Li JJ, Mitchell MJ (2024) Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain. Nano Lett 25(2):800\u2013810. https:\/\/doi.org\/10.1021\/acs.nanolett.4c05186","journal-title":"Nano Lett"},{"issue":"1","key":"2386_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, Matsumoto M, Kato D, Ono R, Kiyama H, Moorhouse AJ (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10(1):5816. https:\/\/doi.org\/10.1038\/s41467-019-13812-z","journal-title":"Nat Commun"},{"issue":"1","key":"2386_CR71","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12951-025-03719-x","volume":"23","author":"YM Hassan","year":"2025","unstructured":"Hassan YM, Wanas A, Ali AA, El-Sayed WM (2025) Integrating artificial intelligence with nanodiagnostics for early detection and precision management of neurodegenerative diseases. J Nanobiotechnol 23(1):668. https:\/\/doi.org\/10.1186\/s12951-025-03719-x","journal-title":"J Nanobiotechnol"},{"key":"2386_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1515981","volume":"15","author":"Y He","year":"2024","unstructured":"He Y, Lu W, Zhou X, Mu J, Shen W (2024a) Unraveling Alzheimer\u2019s disease: insights from single-cell sequencing and spatial transcriptomic. Front Neurol 15:1515981. https:\/\/doi.org\/10.3389\/fneur.2024.1515981","journal-title":"Front Neurol"},{"issue":"1","key":"2386_CR73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3762\/bjnano.15.47","volume":"15","author":"S He","year":"2024","unstructured":"He S, Abarrategi JS, Bediaga H, Arrasate S, Gonz\u00e1lez-D\u00edaz H (2024b) On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems. Beilstein J Nanotechnol 15(1):535\u2013555. https:\/\/doi.org\/10.3762\/bjnano.15.47","journal-title":"Beilstein J Nanotechnol"},{"issue":"10","key":"2386_CR74","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E (2018) Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19(10):610\u2013621. https:\/\/doi.org\/10.1038\/s41583-018-0055-7","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"2386_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P (2025) Neuroinflammation in Alzheimer disease. Nat Rev Immunol 25(5):321\u2013352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7","journal-title":"Nat Rev Immunol"},{"key":"2386_CR76","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.10.034","volume":"314","author":"SD Hettiarachchi","year":"2019","unstructured":"Hettiarachchi SD, Zhou Y, Seven E, Lakshmana MK, Kaushik AK, Chand HS, Leblanc RM (2019) Nanoparticle-mediated approaches for Alzheimer\u2019s disease pathogenesis, diagnosis, and therapeutics. J Control Release 314:125\u2013140. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.034","journal-title":"J Control Release"},{"key":"2386_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118340","volume":"299","author":"Z Hosni","year":"2025","unstructured":"Hosni Z, Achour S, Saadi F, Chen Y, Al Qaraghuli M (2025) Machine learning-driven nanoparticle toxicity. Ecotoxicol Environ Saf 299:118340. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.118340","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"2386_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27(1):36\u201347. https:\/\/doi.org\/10.1111\/cns.13569","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2386_CR79","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.14336\/AD.2023.0807","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F (2024) Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation. Aging Dis 15(3):1155. https:\/\/doi.org\/10.14336\/AD.2023.0807","journal-title":"Aging Dis"},{"key":"2386_CR80","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S581479","author":"Q Huang","year":"2026","unstructured":"Huang Q, Zou J, Luan F, Shi Y (2026a) Tailoring polydopamine nanoparticle size through synthesis conditions and defining their antioxidant and neuroprotective efficacy. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S581479","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2386_CR81","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7150\/thno.117143","volume":"16","author":"Q Huang","year":"2026","unstructured":"Huang Q, Wang S, Liu Z, Rao L, Cheng K, Mao X (2026b) Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics 16(1):545. https:\/\/doi.org\/10.7150\/thno.117143","journal-title":"Theranostics"},{"issue":"7784","key":"2386_CR82","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"issue":"1","key":"2386_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-026-00540-w","volume":"15","author":"A Jauhari","year":"2026","unstructured":"Jauhari A, Singh T, Carlisle DL, Friedlander RM (2026) Mitochondrial DNA: a molecular switch driving sterile neuroinflammation. Transl Neurodegener 15(1):5. https:\/\/doi.org\/10.1186\/s40035-026-00540-w","journal-title":"Transl Neurodegener"},{"issue":"s1","key":"2386_CR84","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3233\/JPD-223338","volume":"12","author":"S Jewell","year":"2022","unstructured":"Jewell S, Herath AM, Gordon R (2022) Inflammasome activation in Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S113\u2013S128. https:\/\/doi.org\/10.3233\/JPD-223338","journal-title":"J Parkinsons Dis"},{"key":"2386_CR85","doi-asserted-by":"publisher","first-page":"p.1510798","DOI":"10.3389\/fphar.2025.1510798","volume":"16","author":"J Jia","year":"2025","unstructured":"Jia J, Zhao S, Zhao J, Gao Y (2025) Engineered nanoparticles for the treatment of Alzheimer\u2019s disease. Front Pharmacol 16:p.1510798. https:\/\/doi.org\/10.3389\/fphar.2025.1510798","journal-title":"Front Pharmacol"},{"issue":"7","key":"2386_CR86","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.nano.2015.04.015","volume":"11","author":"DH Jo","year":"2015","unstructured":"Jo DH, Kim JH, Lee TG, Kim JH (2015) Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomedicine (Lond) 11(7):1603\u20131611. https:\/\/doi.org\/10.1016\/j.nano.2015.04.015","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"2386_CR87","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/21691401.2026.2617707","volume":"54","author":"T Jootar","year":"2026","unstructured":"Jootar T, Hongeng S, Chiangjong W (2026) Engineering nanobodies for drug delivery systems in Alzheimer\u2019s disease. Artif Cells Nanomed Biotechnol 54(1):104\u2013118. https:\/\/doi.org\/10.1080\/21691401.2026.2617707","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"2386_CR88","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-chembioeng-092220-030853","volume":"13","author":"A Joseph","year":"2022","unstructured":"Joseph A, Nance E (2022) Nanotherapeutics and the brain. Annu Rev Chem Biomol Eng 13(1):325\u2013346. https:\/\/doi.org\/10.1146\/annurev-chembioeng-092220-030853","journal-title":"Annu Rev Chem Biomol Eng"},{"issue":"2","key":"2386_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38(2):209\u2013223. https:\/\/doi.org\/10.1016\/j.immuni.2013.02.003","journal-title":"Immunity"},{"issue":"7575","key":"2386_CR90","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526(7575):666\u2013671. https:\/\/doi.org\/10.1038\/nature15541","journal-title":"Nature"},{"issue":"1","key":"2386_CR91","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1039\/d5bm01080b","volume":"14","author":"J Ke","year":"2026","unstructured":"Ke J, Ding J, Xu Y, Yu C, Hong Y, Li S, Meng T, Ping Y, Yuan H, Hu F (2026) Engineering microglial exosome-mediated microRNA-124-3p delivery for Alzheimer\u2019s disease combinational therapy. Biomater Sci 14(1):186\u2013197. https:\/\/doi.org\/10.1039\/d5bm01080b","journal-title":"Biomater Sci"},{"issue":"7","key":"2386_CR92","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"1","key":"2386_CR93","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RS, Kanneganti TD (2020) Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol 38(1):567\u2013595. https:\/\/doi.org\/10.1146\/annurev-immunol-073119-095439","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2386_CR94","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cimb47010008","volume":"47","author":"ME Kim","year":"2024","unstructured":"Kim ME, Lee JS (2024) Mechanisms and emerging regulators of neuroinflammation: exploring new therapeutic strategies for neurological disorders. Curr Issues Mol Biol 47(1):8. https:\/\/doi.org\/10.3390\/cimb47010008","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"2386_CR95","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM (2022) The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry 27(6):2659\u20132673. https:\/\/doi.org\/10.1038\/s41380-022-01511-z","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2386_CR96","doi-asserted-by":"publisher","first-page":"p.75","DOI":"10.1007\/s12035-025-05417-z","volume":"63","author":"U Kochman","year":"2026","unstructured":"Kochman U, Sitka H, Ku\u017aniar J, Czaja M, Kozubek P, Besz\u0142ej JA, Leszek J (2026) Targeted nanoparticles for drug delivery across the blood\u2013brain barrier in early and late stages of Alzheimer\u2019s disease: a review. Mol Neurobiol 63(1):p.75. https:\/\/doi.org\/10.1007\/s12035-025-05417-z","journal-title":"Mol Neurobiol"},{"issue":"8","key":"2386_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082042","volume":"15","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang SW, Yoo TH (2023) Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics 15(8):p.2042. https:\/\/doi.org\/10.3390\/pharmaceutics15082042","journal-title":"Pharmaceutics"},{"issue":"3","key":"2386_CR98","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019loughlin E, Xu Y, Fanek Z, Greco DJ (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566\u2013581. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"issue":"18","key":"2386_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189178","volume":"26","author":"A Krsek","year":"2025","unstructured":"Krsek A, Schleicher LMS, Jagodic A, Baticic L (2025) Nanomedicine-driven modulation of the gut\u2013brain axis: innovative approaches to managing chronic inflammation in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 26(18):9178. https:\/\/doi.org\/10.3390\/ijms26189178","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2386_CR100","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70215","volume":"62","author":"M Kudpaje","year":"2025","unstructured":"Kudpaje M, Joghee S, Ram Kumar RM (2025) Exosomes as a nanotheranostic platform in brain diseases. Eur J Neurosci 62(3):e70215. https:\/\/doi.org\/10.1111\/ejn.70215","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2386_CR101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5599\/admet.2043","volume":"12","author":"M Kulkarni","year":"2024","unstructured":"Kulkarni M, Patel K, Patel A, Patel S, Desai J, Patel M, Shah U, Patel A, Solanki N (2024) Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: a comprehensive review. ADMET DMPK 12(1):63\u2013105. https:\/\/doi.org\/10.5599\/admet.2043","journal-title":"ADMET DMPK"},{"key":"2386_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.10.004","author":"PA Lafon","year":"2025","unstructured":"Lafon PA, Pr\u00e9zeau L, Pin JP, Rondard P (2025) Nanobodies: a new paradigm for brain disorder therapies. Trends Pharmacol Sci. https:\/\/doi.org\/10.1016\/j.tips.2025.10.004","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2386_CR103","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","volume":"35","author":"UH Langen","year":"2019","unstructured":"Langen UH, Ayloo S, Gu C (2019) Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol 35(1):591\u2013613. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617-062608","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"24","key":"2386_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245985","volume":"29","author":"AM Lankoff","year":"2024","unstructured":"Lankoff AM, Czerwi\u0144ska M, Kruszewski M (2024) Advances in nanotheranostic systems for concurrent cancer imaging and therapy: an overview of the last 5 years. Molecules 29(24):p.5985. https:\/\/doi.org\/10.3390\/molecules29245985","journal-title":"Molecules"},{"issue":"1","key":"2386_CR105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau K, Kotzur R, Richter F (2024) Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy. Transl Neurodegener 13(1):37. https:\/\/doi.org\/10.1186\/s40035-024-00430-z","journal-title":"Transl Neurodegener"},{"key":"2386_CR106","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-0716-1693-2_7","volume-title":"Organ-on-a-chip: methods and protocols","author":"SWL Lee","year":"2021","unstructured":"Lee SWL, Rogosic R, Venturi C, Raimondi MT, Pavesi A, Adriani G (2021) A human neurovascular unit on-a-chip. Organ-on-a-chip: methods and protocols. Springer US, New York, NY, pp 107\u2013119. https:\/\/doi.org\/10.1007\/978-1-0716-1693-2_7"},{"issue":"5","key":"2386_CR107","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1039\/d5bm01582k","volume":"14","author":"S Lee","year":"2026","unstructured":"Lee S, Lee J, Lee K (2026) Translational roadmap of BBB-targeted nanoparticle strategies for neuroregenerative therapy in neurodegenerative diseases. Biomater Sci 14(5):1206\u20131218. https:\/\/doi.org\/10.1039\/d5bm01582k","journal-title":"Biomater Sci"},{"issue":"4","key":"2386_CR108","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","volume":"18","author":"T Lei","year":"2024","unstructured":"Lei T, Yang Z, Jiang C, Wang X, Yang W, Yang X, Xie R, Tong F, Xia X, Huang Q, Du Y (2024a) Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy. ACS Nano 18(4):3234\u20133250. https:\/\/doi.org\/10.1021\/acsnano.3c09715","journal-title":"ACS Nano"},{"key":"2386_CR109","doi-asserted-by":"publisher","first-page":"204173142412370","DOI":"10.1177\/20417314241237","volume":"15","author":"SY Lei","year":"2024","unstructured":"Lei SY, Yang YQ, Liu JC, Zhang DH, Qu Y, Sun YY, Zhu HJ, Zhou SY, Yang Y, Guo ZN (2024b) Nanodrug delivery systems for regulating microglial polarization in ischemic stroke treatment: a review. J Tissue Eng 15:20417314241237052. https:\/\/doi.org\/10.1177\/20417314241237","journal-title":"J Tissue Eng"},{"issue":"4","key":"2386_CR110","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA (2018) Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol 18(4):225\u2013242. https:\/\/doi.org\/10.1038\/nri.2017.125","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2386_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54382-z","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Chen G, Zhong H, Li T, Lin M, Wei H, Zhang Q, Chen Q, Huang J, Shuai X (2024) \u03b3-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma. Nat Commun 15(1):10418. https:\/\/doi.org\/10.1038\/s41467-024-54382-z","journal-title":"Nat Commun"},{"issue":"1","key":"2386_CR112","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-025-03563-8","volume":"22","author":"H Li","year":"2025","unstructured":"Li H, Cai R, Zhou Y, Jiang Y, Tan S (2025a) cGAS-STING signaling in brain aging and neurodegeneration: molecular links and therapeutic perspectives. J Neuroinflammation 22(1):235. https:\/\/doi.org\/10.1186\/s12974-025-03563-8","journal-title":"J Neuroinflammation"},{"issue":"11","key":"2386_CR113","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/cbe.5c00048","volume":"2","author":"M Li","year":"2025","unstructured":"Li M, Li QZ, Zhao Y, Gao X (2025b) Recent advances in machine learning models for predicting toxicity of inorganic nanoparticles. Chem Bio Eng 2(11):647. https:\/\/doi.org\/10.1021\/cbe.5c00048","journal-title":"Chem Bio Eng"},{"issue":"1","key":"2386_CR114","doi-asserted-by":"publisher","first-page":"2645830","DOI":"10.1080\/10717544.2026.2645830","volume":"33","author":"J Li","year":"2026","unstructured":"Li J, Guo L, Cai W, Mei J, Liu J, Liu Y (2026) Overcoming the blood-brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer\u2019s disease. Drug Deliv 33(1):2645830. https:\/\/doi.org\/10.1080\/10717544.2026.2645830","journal-title":"Drug Deliv"},{"key":"2386_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07604-x","author":"Y Liao","year":"2025","unstructured":"Liao Y, Mu G, Deng S, Lu B, Zheng M (2025) Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-025-07604-x","journal-title":"J Transl Med"},{"issue":"6","key":"2386_CR116","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Barres BA (2017) Reactive astrocytes: production, function, and therapeutic potential. Immunity 46(6):957\u2013967. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.006","journal-title":"Immunity"},{"key":"2386_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxmate.2025.101253","volume":"9","author":"W Lin","year":"2025","unstructured":"Lin W, Miao H, Zhang J, Li J, Lv X, Ding X, Liu Y, Hu YJ (2025a) Regulation of the antioxidant structure of polydopamine nanomaterials: mechanisms, strategies, and applications in reactive oxygen species-mediated diseases. Next Materials 9:101253. https:\/\/doi.org\/10.1016\/j.nxmate.2025.101253","journal-title":"Next Materials"},{"key":"2386_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1616899","volume":"16","author":"S Lin","year":"2025","unstructured":"Lin S, Zhan Y, Wang R, Pei J (2025b) Decoding neuroinflammation in Alzheimer\u2019s disease: a multi-omics and AI-driven perspective for precision medicine. Front Immunol 16:p.1616899. https:\/\/doi.org\/10.3389\/fimmu.2025.1616899","journal-title":"Front Immunol"},{"issue":"9","key":"2386_CR119","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/cr400407a","volume":"114","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ai K, Lu L (2014) Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem Rev 114(9):5057\u20135115. https:\/\/doi.org\/10.1021\/cr400407a","journal-title":"Chem Rev"},{"key":"2386_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2025.101150","author":"M Liu","year":"2025","unstructured":"Liu M, Cao L, Huang H, Yang J, Zhang H, Xu Z (2025a) Gut microbiota\u2013neuroinflammation axis: a new mechanism and therapeutic target for comorbid depression in epilepsy. Brain Behav Immun Health. https:\/\/doi.org\/10.1016\/j.bbih.2025.101150","journal-title":"Brain Behav Immun Health"},{"issue":"17","key":"2386_CR121","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1097\/CM9.0000000000003695","volume":"138","author":"H Liu","year":"2025","unstructured":"Liu H, Chen Y, Zhang J, Chen X (2025b) Adaptive immunity in the neuroinflammation of Alzheimer\u2019s disease. Chin Med J 138(17):2116\u20132129. https:\/\/doi.org\/10.1097\/CM9.0000000000003695","journal-title":"Chin Med J"},{"issue":"1","key":"2386_CR122","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-025-03247-8","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Wang T, Dong J, Lu Y (2025c) The blood\u2013brain barriers: novel nanocarriers for central nervous system diseases. J Nanobiotechnology 23(1):146. https:\/\/doi.org\/10.1186\/s12951-025-03247-8","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"2386_CR123","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1038\/s41380-026-03529-z","volume":"31","author":"P Liu","year":"2026","unstructured":"Liu P, Sun T, Yang J, Li H, Min W, Zhou X, Xiong R, Wu J, Huang Y, Li Y, Yuan M (2026b) Comprehensive single-cell transcriptomic atlas of microglia in Alzheimer\u2019s disease mouse models. Mol Psychiatry 31(7):4164\u20134180. https:\/\/doi.org\/10.1038\/s41380-026-03529-z","journal-title":"Mol Psychiatry"},{"key":"2386_CR124","doi-asserted-by":"publisher","DOI":"10.1080\/14686996.2026.2699624","author":"Y Liu","year":"2026","unstructured":"Liu Y, Luo B, Xu Y, Liu D, Wang Q (2026a) Targeting microglia-mediated neuroinflammation via pH-responsive lipid nanoparticle delivery of HDAC inhibitor RGFP966 in ischemic stroke. Sci Techn Adv Mater. https:\/\/doi.org\/10.1080\/14686996.2026.2699624","journal-title":"Sci Techn Adv Mater"},{"issue":"1","key":"2386_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, Foo JB, Ong YS, How CW, Khaw KY (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"key":"2386_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1542369","volume":"16","author":"Y Ma","year":"2025","unstructured":"Ma Y, Song R, Duan C (2025a) Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation. Front Immunol 16:1542369. https:\/\/doi.org\/10.3389\/fimmu.2025.1542369","journal-title":"Front Immunol"},{"issue":"1","key":"2386_CR127","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12951-025-03263-8","volume":"23","author":"J Ma","year":"2025","unstructured":"Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding C, Wei P, Yi X, Lin Z, Fang W (2025b) Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate A\u03b2 oligomer-induced neurotoxicity in Alzheimer\u2019s disease. J Nanobiotechnol 23(1):181. https:\/\/doi.org\/10.1186\/s12951-025-03263-8","journal-title":"J Nanobiotechnol"},{"issue":"17","key":"2386_CR128","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1080\/17435889.2025.2552103","volume":"20","author":"AK Mahanta","year":"2025","unstructured":"Mahanta AK, Gothwal A, Chaulagain B, Muolokwu CE, Tagoe B, Lamsal B, Belin M, Singh J (2025) Emerging anti-inflammatory nanosystems targeted to the brain. Nanomedicine (Lond) 20(17):2237\u20132255. https:\/\/doi.org\/10.1080\/17435889.2025.2552103","journal-title":"Nanomedicine (Lond)"},{"issue":"7","key":"2386_CR129","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","volume":"8","author":"M Mahmoudi","year":"2023","unstructured":"Mahmoudi M, Landry MP, Moore A, Coreas R (2023) The protein corona from nanomedicine to environmental science. Nat Rev Mater 8(7):422\u2013438. https:\/\/doi.org\/10.1038\/s41578-023-00552-2","journal-title":"Nat Rev Mater"},{"issue":"1","key":"2386_CR130","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ph18010104","volume":"18","author":"R Mallick","year":"2025","unstructured":"Mallick R, Basak S, Chowdhury P, Bhowmik P, Das RK, Banerjee A, Paul S, Pathak S, Duttaroy AK (2025) Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies. Pharmaceuticals (Basel) 18(1):104. https:\/\/doi.org\/10.3390\/ph18010104","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2386_CR131","doi-asserted-by":"publisher","DOI":"10.36922\/ijb.5717","volume":"11","author":"H Mao","year":"2024","unstructured":"Mao H, Yu L, Qiao Y, Liu M, Dai X, Cheng H (2024) A 3D-bioprinted neuroinflammatory co-culture model for in vitro study of Parkinson\u2019s disease pathology. Int J Bioprint 11(1):5717. https:\/\/doi.org\/10.36922\/ijb.5717","journal-title":"Int J Bioprint"},{"issue":"5","key":"2386_CR132","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"T Masuda","year":"2020","unstructured":"Masuda T, Sankowski R, Staszewski O, Prinz M (2020) Microglia heterogeneity in the single-cell era. Cell Rep 30(5):1271\u20131281. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.010","journal-title":"Cell Rep"},{"issue":"7761","key":"2386_CR133","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, Martorell AJ (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570(7761):332\u2013337. https:\/\/doi.org\/10.1038\/s41586-019-1195-2","journal-title":"Nature"},{"issue":"1","key":"2386_CR134","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol 23(1):329. https:\/\/doi.org\/10.1186\/s12951-025-03352-8","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"2386_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.70150","volume":"6","author":"L Mei","year":"2025","unstructured":"Mei L, Wang X, Hu Z, Yan J, Wang X, Wang H, Hou Y, Zhang P, Ding Q (2025) Nanozymes for non-neoplastic diseases: catalytic therapy redefined. Aggregate 6(11):e70150. https:\/\/doi.org\/10.1002\/agt2.70150","journal-title":"Aggregate"},{"issue":"6","key":"2386_CR136","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","volume":"101","author":"M Merlini","year":"2019","unstructured":"Merlini M, Rafalski VA, Coronado PER, Gill TM, Ellisman M, Muthukumar G, Subramanian KS, Ryu JK, Syme CA, Davalos D, Seeley WW (2019) Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer\u2019s disease model. Neuron 101(6):1099\u20131108. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.014","journal-title":"Neuron"},{"issue":"2","key":"2386_CR137","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20(2):101\u2013124. https:\/\/doi.org\/10.1038\/s41573-020-0090-8","journal-title":"Nat Rev Drug Discov"},{"key":"2386_CR138","first-page":"34","volume":"24","author":"PN Mohammed","year":"2025","unstructured":"Mohammed PN, Hussen NH, Hasan AH, Salh HJH, Jamalis J, Ahmed S, Kamal MA (2025) A review on the role of nanoparticles for targeted brain drug delivery: synthesis, characterization, and applications. EXCLI J 24:34","journal-title":"EXCLI J"},{"issue":"7806","key":"2386_CR139","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D\u2019Orazio LM, Buennagel DP (2020) APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71\u201376. https:\/\/doi.org\/10.1038\/s41586-020-2247-3","journal-title":"Nature"},{"issue":"1","key":"2386_CR140","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cells14010036","volume":"14","author":"E Moustakli","year":"2025","unstructured":"Moustakli E, Stavros S, Katopodis P, Skentou C, Potiris A, Panagopoulos P, Domali E, Arkoulis I, Karampitsakos T, Sarafi E, Michaelidis TM (2025) Oxidative stress and the NLRP3 inflammasome: focus on female fertility and reproductive health. Cells 14(1):36. https:\/\/doi.org\/10.3390\/cells14010036","journal-title":"Cells"},{"issue":"3","key":"2386_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22982","volume":"85","author":"MA Mustafa","year":"2025","unstructured":"Mustafa MA, Bansal P, Pallavi MS, Panigrahi R, Nathiya D, Kumar S, Al\u2010Hasnaawei S, Chauhan AS, Singla S (2025) Exploring the role of NLRP3 in neurodegeneration: cutting\u2010edge therapeutic strategies and inhibitors. Dev Neurobiol 85(3):e22982. https:\/\/doi.org\/10.1002\/dneu.22982","journal-title":"Dev Neurobiol"},{"key":"2386_CR142","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","volume":"116","author":"A Naeem","year":"2024","unstructured":"Naeem A, Prakash R, Kumari N, Khan MA, Khan AQ, Uddin S, Verma S, Robertson AA, Boltze J, Raza SS (2024) MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease. Brain Behav Immun 116:70\u201384. https:\/\/doi.org\/10.1016\/j.bbi.2023.11.031","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2386_CR143","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TL (2019) Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276. https:\/\/doi.org\/10.1038\/s41591-018-0297-y","journal-title":"Nat Med"},{"key":"2386_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108119","volume":"234","author":"G Nehra","year":"2022","unstructured":"Nehra G, Bauer B, Hartz AM (2022) Blood-brain barrier leakage in Alzheimer\u2019s disease: from discovery to clinical relevance. Pharmacol Ther 234:108119. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108119","journal-title":"Pharmacol Ther"},{"issue":"19","key":"2386_CR145","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.28.672885","volume":"15","author":"BB Nguyen","year":"2026","unstructured":"Nguyen BB, Lowe NM, Kellogg S, Huang KW, O\u2019Toole H, Hale EJ, Shirure VS, Shergill BS, George SC, Carney RP (2026) A physiological microfluidic blood\u2013brain-barrier model for in vitro study of nanoparticle trafficking and accumulation. Adv Healthcare Mater 15(19):e00019. https:\/\/doi.org\/10.1101\/2025.08.28.672885","journal-title":"Adv Healthcare Mater"},{"key":"2386_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1590909","volume":"16","author":"W Nie","year":"2025","unstructured":"Nie W, Yue Y, Hu J (2025) The role of monocytes and macrophages in the progression of Alzheimer\u2019s disease. Front Immunol 16:1590909. https:\/\/doi.org\/10.3389\/fimmu.2025.1590909","journal-title":"Front Immunol"},{"issue":"5","key":"2386_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04920-8","volume":"13","author":"H Ning","year":"2022","unstructured":"Ning H, Zhang L, Zhu B, Zhou X, Zhang T, Ma T (2022) TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p\/NFATC3 in A\u03b2-microenvironment. Cell Death Dis 13(5):457. https:\/\/doi.org\/10.1038\/s41419-022-04920-8","journal-title":"Cell Death Dis"},{"key":"2386_CR148","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.107552","volume":"14","author":"N Nirakis","year":"2025","unstructured":"Nirakis N, Dimothyra S, Karadima E, Alexaki VI (2025) Metabolic regulation of immune memory and function of microglia. Elife 14:e107552. https:\/\/doi.org\/10.7554\/eLife.107552","journal-title":"Elife"},{"issue":"9","key":"2386_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094437","volume":"26","author":"A Nowaczewska-Kuchta","year":"2025","unstructured":"Nowaczewska-Kuchta A, Ksiazek-Winiarek D, Glabinski A (2025) Interaction between neutrophils and elements of the blood\u2013brain barrier in the context of multiple sclerosis and ischemic stroke. Int J Mol Sci 26(9):p.4437. https:\/\/doi.org\/10.3390\/ijms26094437","journal-title":"Int J Mol Sci"},{"key":"2386_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2025.1655471","volume":"7","author":"H Onohuean","year":"2025","unstructured":"Onohuean H, Naik Bukke SP, Thalluri C, Abass KS, Choonara YE (2025) Exosome engineering for targeted therapy of brain-infecting pathogens: molecular tools, delivery platforms, and translational advances. Front Med Technol 7:p.1655471. https:\/\/doi.org\/10.3389\/fmedt.2025.1655471","journal-title":"Front Med Technol"},{"issue":"23","key":"2386_CR151","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/d4na00501e","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, Thalla M, Jain A, Palakurthi S (2024) A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv 6(23):5803\u20135826. https:\/\/doi.org\/10.1039\/d4na00501e","journal-title":"Nanoscale Adv"},{"issue":"8","key":"2386_CR152","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1021\/acschemneuro.5c00063","volume":"16","author":"L Palanivelu","year":"2025","unstructured":"Palanivelu L, Chang CW, Li SJ, Liang YW, Lo YC, Chen YY (2025) Interplay of neuroinflammation and gut microbiota dysbiosis in Alzheimer\u2019s disease using diffusion kurtosis imaging biomarker in 3\u00d7 Tg-AD mouse models. ACS Chem Neurosci 16(8):1511\u20131528. https:\/\/doi.org\/10.1021\/acschemneuro.5c00063","journal-title":"ACS Chem Neurosci"},{"issue":"21","key":"2386_CR153","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, Amit I, Audinat E, Bechmann I, Bennett M, Bennett F (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110(21):3458\u20133483. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020","journal-title":"Neuron"},{"key":"2386_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2023.1227816","volume":"3","author":"WM Pardridge","year":"2023","unstructured":"Pardridge WM (2023) Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. Front Drug Deliv 3:p.1227816. https:\/\/doi.org\/10.3389\/fddev.2023.1227816","journal-title":"Front Drug Deliv"},{"issue":"9","key":"2386_CR155","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, Ottoy J (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27(9):1592\u20131599. https:\/\/doi.org\/10.1038\/s41591-021-01456-w","journal-title":"Nat Med"},{"key":"2386_CR156","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2020.03.020","volume":"322","author":"C Peng","year":"2020","unstructured":"Peng C, Huang Y, Zheng J (2020) Renal clearable nanocarriers: overcoming the physiological barriers for precise drug delivery and clearance. J Control Release 322:64\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.020","journal-title":"J Control Release"},{"issue":"2","key":"2386_CR157","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/glia.24485","volume":"72","author":"J Penney","year":"2024","unstructured":"Penney J, Ralvenius WT, Loon A, Cerit O, Dileep V, Milo B, Pao PC, Woolf H, Tsai LH (2024) iPSC-derived microglia carrying the TREM2 R47H\/+ mutation are proinflammatory and promote synapse loss. Glia 72(2):452\u2013469. https:\/\/doi.org\/10.1002\/glia.24485","journal-title":"Glia"},{"key":"2386_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1600148","volume":"19","author":"JM Pfaffinger","year":"2025","unstructured":"Pfaffinger JM, Hays KE, Seeley J, Ramesh Babu P, Ryznar R (2025) Gut dysbiosis as a potential driver of Parkinson\u2019s and Alzheimer\u2019s disease pathogenesis. Front Neurosci 19:1600148. https:\/\/doi.org\/10.3389\/fnins.2025.1600148","journal-title":"Front Neurosci"},{"key":"2386_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1638668","volume":"13","author":"MI Prasanth","year":"2025","unstructured":"Prasanth MI, Mallya AR, Cho WC, Mundekkad D (2025) Nano-structured strategies in combatting neurodegeneration. Front Bioeng Biotechnol 13:p.1638668. https:\/\/doi.org\/10.3389\/fbioe.2025.1638668","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2386_CR160","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-025-00515-3","volume":"14","author":"X Qi","year":"2025","unstructured":"Qi X, Zhu K, Ke W, Wang J, Mao S, Chen G (2025) Roles of TREM2 in Alzheimer\u2019s disease. Transl Neurodegener 14(1):55. https:\/\/doi.org\/10.1186\/s40035-025-00515-3","journal-title":"Transl Neurodegener"},{"key":"2386_CR161","doi-asserted-by":"publisher","first-page":"113852","DOI":"10.1016\/j.jconrel.2025.113852","volume":"383","author":"B Qiu","year":"2025","unstructured":"Qiu B, Pompe S, Xenaki KT, Di Maggio A, Moreno CB, En Henegouwen PMVB, Mastrobattista E, Oliveira S, Caiazzo M (2025) Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models. J Controll Release. 383:113852. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113852","journal-title":"J Controll Release."},{"issue":"1","key":"2386_CR162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","volume":"20","author":"S Quan","year":"2025","unstructured":"Quan S, Fu X, Cai H, Ren Z, Xu Y, Jia L (2025) The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer\u2019s disease. Mol Neurodegener 20(1):25. https:\/\/doi.org\/10.1186\/s13024-025-00815-2","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2386_CR163","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2465909","volume":"32","author":"M Rafiei","year":"2025","unstructured":"Rafiei M, Shojaei A, Chau Y (2025) Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia. Drug Deliv 32(1):2465909. https:\/\/doi.org\/10.1080\/10717544.2025.2465909","journal-title":"Drug Deliv"},{"issue":"8","key":"2386_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309225","volume":"36","author":"WT Ralvenius","year":"2024","unstructured":"Ralvenius WT, Andresen JL, Huston MM, Penney J, Bonner JM, Fenton OS, Langer R, Tsai LH (2024) Nanoparticle\u2010mediated delivery of anti\u2010PU. 1 siRNA via localized intracisternal administration reduces neuroinflammation. Adv Mater 36(8):2309225. https:\/\/doi.org\/10.1002\/adma.202309225","journal-title":"Adv Mater"},{"issue":"1","key":"2386_CR165","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/0118715273373041250707012835","volume":"25","author":"A Rana","year":"2026","unstructured":"Rana A, Malviya R, Rajput S, Sridhar SB, Wadhwa T (2026) Trends in nanoparticle-based strategies for the management of neuroinflammation. CNS Neurol Disord Drug Targets 25(1):39\u201355. https:\/\/doi.org\/10.2174\/0118715273373041250707012835","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"2386_CR166","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8):987\u2013991. https:\/\/doi.org\/10.1038\/nn.4338","journal-title":"Nat Neurosci"},{"issue":"3","key":"2386_CR167","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4155\/tde.12.165","volume":"4","author":"J Rautio","year":"2013","unstructured":"Rautio J, Gynther M, Laine K (2013) LAT1-mediated prodrug uptake: a way to breach the blood\u2013brain barrier? Ther Deliv 4(3):281\u2013284. https:\/\/doi.org\/10.4155\/tde.12.165","journal-title":"Ther Deliv"},{"key":"2386_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.07.030","author":"F Ren","year":"2025","unstructured":"Ren F, Wei J, Chen Q, Hu M, Yu L, Mi J, Zhou X, Qin D, Wu J, Wu A (2025) Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: progress, challenges, and future directions. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2025.07.030","journal-title":"Acta Pharm Sin B"},{"key":"2386_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2026.1810486","volume":"20","author":"N Roamcharern","year":"2026","unstructured":"Roamcharern N, Yubolphan R (2026) Overcoming the blood\u2013brain barrier in Alzheimer\u2019s disease: translational perspectives on advanced drug delivery platforms. Front Neurosci 20:p.1810486. https:\/\/doi.org\/10.3389\/fnins.2026.1810486","journal-title":"Front Neurosci"},{"issue":"1","key":"2386_CR170","doi-asserted-by":"publisher","first-page":"5","DOI":"10.31083\/j.jin2101005","volume":"21","author":"M Rock","year":"2022","unstructured":"Rock M, Zouganelis GD, de Andrade AFB, Drake SJ, Alexiou A, Albrakati A, Batiha GES, Illingworth TA (2022) Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques\u2014an in silico study. J Integr Neurosci 21(1):5","journal-title":"J Integr Neurosci"},{"issue":"35","key":"2386_CR171","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady0240","volume":"11","author":"WM Rosencrans","year":"2025","unstructured":"Rosencrans WM, Lee RW, McGraw L, Horsburgh I, Wang TY, Quan B, Huynh D, Johnston JA, Chan DC, Chou TF (2025) Putative PINK1\/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stress. Sci Adv 11(35):eady0240. https:\/\/doi.org\/10.1126\/sciadv.ady0240","journal-title":"Sci Adv"},{"issue":"9","key":"2386_CR172","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1021\/acsami.7b19865","volume":"10","author":"JH Ryu","year":"2018","unstructured":"Ryu JH, Messersmith PB, Lee H (2018) Polydopamine surface chemistry: a decade of discovery. ACS Appl Mater Interfaces 10(9):7523. https:\/\/doi.org\/10.1021\/acsami.7b19865","journal-title":"ACS Appl Mater Interfaces"},{"issue":"17\u201318","key":"2386_CR173","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/hum.2024.106","volume":"35","author":"N Saber","year":"2024","unstructured":"Saber N, Senti ME, Schiffelers RM (2024) Lipid nanoparticles for nucleic acid delivery beyond the liver. Hum Gene Ther 35(17\u201318):617\u2013627. https:\/\/doi.org\/10.1089\/hum.2024.106","journal-title":"Hum Gene Ther"},{"issue":"4","key":"2386_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102776","volume":"36","author":"S Salarpour","year":"2025","unstructured":"Salarpour S, Dourandish F, Salajegheh A, Hashemi S (2025) The role of exosomes as oligonucleotide delivery system for managing alpha-synuclein in Parkinson\u2019s disease: a systematic review of in vivo studies. Mol Ther Nucleic Acids 36(4):102776. https:\/\/doi.org\/10.1016\/j.omtn.2025.102776","journal-title":"Mol Ther Nucleic Acids"},{"key":"2386_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.965169","volume":"14","author":"B Santos-Lima","year":"2022","unstructured":"Santos-Lima B, Pietronigro EC, Terrabuio E, Zenaro E, Constantin G (2022) The role of neutrophils in the dysfunction of central nervous system barriers. Front Aging Neurosci 14:965169. https:\/\/doi.org\/10.3389\/fnagi.2022.965169","journal-title":"Front Aging Neurosci"},{"key":"2386_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/alz70855_100929","volume":"21","author":"K Satoh","year":"2025","unstructured":"Satoh K, Zhou Y, Dodd RB, Enomoto M, Zhang Y, Bohm C, Chen F, Qamar S, Rashid M, Sevalle J, Acheson B (2025) Sialylated clusterin binds CD33 to regulate microglial functions in Alzheimer\u2019s disease. Alzheimers Dement 21:e100929. https:\/\/doi.org\/10.1002\/alz70855_100929","journal-title":"Alzheimers Dement"},{"issue":"10284","key":"2386_CR177","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, Van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"41","key":"2386_CR178","doi-asserted-by":"publisher","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","volume":"19","author":"M Sela","year":"2025","unstructured":"Sela M, Chen G, Kadosh H, Kagan T, Nicola R, Turutov S, Richtman Y, Zhige L, Albalak Menasherov MR, Kagan S, Schroeder T (2025) AI-validated brain targeted mRNA lipid nanoparticles with neuronal tropism. ACS Nano 19(41):36106\u201336128. https:\/\/doi.org\/10.1021\/acsnano.4c15013","journal-title":"ACS Nano"},{"issue":"10","key":"2386_CR179","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/pharmaceutics17101336","volume":"17","author":"DR Serrano","year":"2025","unstructured":"Serrano DR, Juste F, Anaya BJ, Ramirez BI, S\u00e1nchez-Guirales SA, Quispillo JM, Hernandez EM, Simon JA, Trallero JM, Serrano C, Rawat S (2025) Exosome-based drug delivery: a next-generation platform for cancer, infection, neurological and immunological diseases, gene therapy and regenerative medicine. Pharmaceutics 17(10):1336. https:\/\/doi.org\/10.3390\/pharmaceutics17101336","journal-title":"Pharmaceutics"},{"key":"2386_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118548","volume":"192","author":"M Shahlaei","year":"2025","unstructured":"Shahlaei M, Afkhami H, Ahmadieh-Yazdi A, Mirmazloumi SH, Sahraei SS, Akbari M, Yang P, Manoochehri H, Tanzadehpanah H, Mahaki H, Sundararaman A (2025) Exosomes in Alzheimer\u2019s disease: from pathogenesis to therapeutics\u2014a comprehensive review of diagnostic and drug delivery applications. Biomed Pharmacother 192:118548. https:\/\/doi.org\/10.1016\/j.biopha.2025.118548","journal-title":"Biomed Pharmacother"},{"key":"2386_CR181","doi-asserted-by":"publisher","DOI":"10.37349\/ebmx.2025.101342","volume":"2","author":"K Shanahan","year":"2025","unstructured":"Shanahan K, Coen D, Nafo W (2025) Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives. Exploration of BioMat-X 2:101342. https:\/\/doi.org\/10.37349\/ebmx.2025.101342","journal-title":"Exploration of BioMat-X"},{"issue":"6753","key":"2386_CR182","doi-asserted-by":"publisher","DOI":"10.1126\/science.adx0043","volume":"388","author":"FD Shi","year":"2025","unstructured":"Shi FD, Yong VW (2025) Neuroinflammation across neurological diseases. Science 388(6753):eadx0043. https:\/\/doi.org\/10.1126\/science.adx0043","journal-title":"Science"},{"issue":"7575","key":"2386_CR183","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"issue":"1","key":"2386_CR184","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/NRR.NRR-D-24-00810","volume":"21","author":"L Shi","year":"2026","unstructured":"Shi L, Liu S, Chen J, Wang H, Wang Z (2026) Microglial polarization pathways and therapeutic drugs targeting activated microglia in traumatic brain injury. Neural Regen Res 21(1):39\u201356. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00810","journal-title":"Neural Regen Res"},{"issue":"8","key":"2386_CR185","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-025-01739-y","volume":"40","author":"MM Shokr","year":"2025","unstructured":"Shokr MM (2025) Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders. Metab Brain Dis 40(8):326. https:\/\/doi.org\/10.1007\/s11011-025-01739-y","journal-title":"Metab Brain Dis"},{"key":"2386_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105940","author":"O Sol","year":"2025","unstructured":"Sol O, Mermoud J, Hallikainen M, Kurl S, Rinne J, Dautzenberg P, Vijverberg EG, Mummery C, B\u00f6rjesson-Hanson A, Jonsson M, Ritchie C (2025) Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer\u2019s disease: a phase 1b\/2a, multicentre, double-blind, randomised, placebo-controlled study. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105940","journal-title":"EBioMedicine"},{"issue":"38","key":"2386_CR187","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403473","volume":"11","author":"Q Song","year":"2024","unstructured":"Song Q, Li J, Li T, Li HW (2024) Nanomaterials that aid in the diagnosis and treatment of Alzheimer\u2019s disease, resolving blood\u2013brain barrier crossing ability. Adv Sci 11(38):2403473. https:\/\/doi.org\/10.1002\/advs.202403473","journal-title":"Adv Sci"},{"key":"2386_CR188","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","volume":"73","author":"SE Storck","year":"2018","unstructured":"Storck SE, Hartz AM, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J, Pietrzik CU (2018) The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM. Brain Behav Immun 73:21\u201333. https:\/\/doi.org\/10.1016\/j.bbi.2018.07.017","journal-title":"Brain Behav Immun"},{"key":"2386_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2026.1735885","volume":"14","author":"F Stucchi","year":"2026","unstructured":"Stucchi F, Li M, Castellano G, Cellesi F (2026) Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front Bioeng Biotechnol 14:1735885. https:\/\/doi.org\/10.3389\/fbioe.2026.1735885","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2386_CR190","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12539-024-00664-5","volume":"17","author":"Y Su","year":"2025","unstructured":"Su Y, Zeng X, Zhang L, Bian Y, Wang Y, Ma B (2025) ABTrans: a transformer-based model for predicting interaction between anti-A\u03b2 antibodies and peptides. Interdiscip Sci Comput Life Sci 17(1):140\u2013152. https:\/\/doi.org\/10.1007\/s12539-024-00664-5","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"9","key":"2386_CR191","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1021\/cbe.4c00105","volume":"1","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhou Y, Rehman M, Wang YF, Guo S (2024) Protein corona of nanoparticles: isolation and analysis. Chem & Bio Engineering 1(9):757. https:\/\/doi.org\/10.1021\/cbe.4c00105","journal-title":"Chem & Bio Engineering"},{"issue":"9","key":"2386_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70386","volume":"6","author":"M Sun","year":"2025","unstructured":"Sun M, Qin F, Bu Q, Zhao Y, Yang X, Zhang D, Cen X (2025a) Exosome\u2010based therapeutics: a natural solution to overcoming the blood\u2013brain barrier in neurodegenerative diseases. MedComm 6(9):p.e70386. https:\/\/doi.org\/10.1002\/mco2.70386","journal-title":"MedComm"},{"key":"2386_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101763","volume":"32","author":"X Sun","year":"2025","unstructured":"Sun X, Xiang T, Xie L, Ren Q, Chang J, Jiang W, Jin Z, Yang X, Ren W, Yu Y (2025b) Recent advances in fluorescent nanomaterials designed for biomarker detection and imaging. Mater Today Bio 32:101763. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101763","journal-title":"Mater Today Bio"},{"issue":"3","key":"2386_CR194","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018a) Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2386_CR195","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2018b) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"issue":"6","key":"2386_CR196","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2386_CR197","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-025-58746-x","volume":"16","author":"K Tang","year":"2025","unstructured":"Tang K, Tang Z, Niu M, Kuang Z, Xue W, Wang X, Liu X, Yu Y, Jeong S, Ma Y, Wu A (2025) Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nat Commun 16(1):3410. https:\/\/doi.org\/10.1038\/s41467-025-58746-x","journal-title":"Nat Commun"},{"issue":"11","key":"2386_CR198","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"2386_CR199","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1042\/CS20256705","volume":"139","author":"S Tian","year":"2025","unstructured":"Tian S, Zhang Y, Liu C, Zhang H, Lu Q, Zhao Y, Fan H (2025b) Double-edged mitophagy: balancing inflammation and resolution in lung disease. Clin Sci 139(19):1047\u20131072. https:\/\/doi.org\/10.1042\/CS20256705","journal-title":"Clin Sci"},{"issue":"22","key":"2386_CR200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2427257122","volume":"122","author":"L Tian","year":"2025","unstructured":"Tian L, Long G, Zhu S, Wang Y, Xu P, Liu L, Yao H, Fang S, Chen S, Li S (2025c) Nanoimmunomodulation of the A\u03b2-STING feedback machinery in microglia for Alzheimer\u2019s disease treatment. Proc Natl Acad Sci U S A 122(22):e2427257122. https:\/\/doi.org\/10.1073\/pnas.2427257122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2386_CR201","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu2708","author":"C Tian","year":"2025","unstructured":"Tian C, Ao Z, Cerneckis J, Cai H, Chen L, Niu H, Takayama K, Kim J, Shi Y, Gu M, Kanekiyo T (2025a) Understanding monocyte-driven neuroinflammation in Alzheimer\u2019s disease using human brain organoid microphysiological systems. bioRxiv. https:\/\/doi.org\/10.1126\/sciadv.adu2708","journal-title":"bioRxiv"},{"issue":"24","key":"2386_CR202","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413302","volume":"25","author":"C Toader","year":"2024","unstructured":"Toader C, Dumitru AV, Eva L, Serban M, Covache-Busuioc RA, Ciurea AV (2024) Nanoparticle strategies for treating CNS disorders: a comprehensive review of drug delivery and theranostic applications. Int J Mol Sci 25(24):13302. https:\/\/doi.org\/10.3390\/ijms252413302","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2386_CR203","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1039\/d3na00180f","volume":"5","author":"A Tomitaka","year":"2023","unstructured":"Tomitaka A, Vashist A, Kolishetti N, Nair M (2023) Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases. Nanoscale Adv 5(17):4354\u20134367. https:\/\/doi.org\/10.1039\/d3na00180f","journal-title":"Nanoscale Adv"},{"issue":"1","key":"2386_CR204","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010038","volume":"13","author":"GR Topal","year":"2020","unstructured":"Topal GR, M\u00e9sz\u00e1ros M, Porkol\u00e1b G, Szecsk\u00f3 A, Polg\u00e1r TF, Sikl\u00f3s L, Deli MA, Veszelka S, Bozkir A (2020) ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood\u2013brain barrier. Pharmaceutics 13(1):p.38. https:\/\/doi.org\/10.3390\/pharmaceutics13010038","journal-title":"Pharmaceutics"},{"issue":"3","key":"2386_CR205","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms24032632","volume":"24","author":"ME Tsitokana","year":"2023","unstructured":"Tsitokana ME, Lafon PA, Prezeau L, Pin JP, Rondard P (2023) Targeting the brain with single-domain antibodies: greater potential than stated so far? Int J Mol Sci 24(3):2632. https:\/\/doi.org\/10.3390\/ijms24032632","journal-title":"Int J Mol Sci"},{"key":"2386_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1682006","volume":"18","author":"JJ Tumpa","year":"2025","unstructured":"Tumpa JJ, Hayder QUA, Maisa NS, Islam MN (2025) Peripheral\u2013central immune interactions in Parkinson\u2019s disease: insights into innate and adaptive immunity. Front Mol Neurosci 18:1682006. https:\/\/doi.org\/10.3389\/fnmol.2025.1682006","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"2386_CR207","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ibra.12199","volume":"11","author":"LA Tziveleka","year":"2025","unstructured":"Tziveleka LA, Cascione M, Pellegrino P, Bianco A, Leporatti S, De Matteis V (2025) Immunomodulatory natural polysaccharide\u2010based nanoparticles for the treatment of neurodegenerative diseases. Ibrain 11(3):277\u2013296. https:\/\/doi.org\/10.1002\/ibra.12199","journal-title":"Ibrain"},{"issue":"5","key":"2386_CR208","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12272-021-01332-8","volume":"44","author":"A Uprety","year":"2021","unstructured":"Uprety A, Kang Y, Kim SY (2021) Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders. Arch Pharm Res 44(5):487\u2013498. https:\/\/doi.org\/10.1007\/s12272-021-01332-8","journal-title":"Arch Pharm Res"},{"issue":"1","key":"2386_CR209","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2016.1142493","volume":"4","author":"MW van Der Helm","year":"2016","unstructured":"van Der Helm MW, Van Der Meer AD, Eijkel JC, van den Berg A, Segerink LI (2016) Microfluidic organ-on-chip technology for blood-brain barrier research. Tissue Barriers 4(1):e1142493. https:\/\/doi.org\/10.1080\/21688370.2016.1142493","journal-title":"Tissue Barriers"},{"key":"2386_CR210","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-082423-041334","author":"H Van Hove","year":"2025","unstructured":"Van Hove H, De Feo D, Greter M, Becher B (2025) Central nervous system macrophages in health and disease. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev-immunol-082423-041334","journal-title":"Annu Rev Immunol"},{"key":"2386_CR211","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79367","author":"I Varsamos","year":"2025","unstructured":"Varsamos I, Patilas C, Galanis A, Zachariou D, Tsalimas G, Sakellariou E, Spyrou I, Rozis M, Kaspiris A, Karampinas PK, Vasiliadis E (2025) The impact of nuclear factor kappa B on the response of microglia in spinal cord injuries. Cureus. https:\/\/doi.org\/10.7759\/cureus.79367","journal-title":"Cureus"},{"issue":"6","key":"2386_CR212","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11(6):p.EMMM201810248. https:\/\/doi.org\/10.15252\/emmm.201810248","journal-title":"EMBO Mol Med"},{"key":"2386_CR213","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1484577","volume":"12","author":"W Wang","year":"2024","unstructured":"Wang W, Shang S, Wang Y, Xu B (2024) Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging. Front Bioeng Biotechnol 12:1484577. https:\/\/doi.org\/10.3389\/fbioe.2024.1484577","journal-title":"Front Bioeng Biotechnol"},{"key":"2386_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1582579","volume":"17","author":"X Wang","year":"2025","unstructured":"Wang X, Li Z, Ma B, Jia Q (2025a) Research progress on microglial pyroptosis and inflammasomes: a comprehensive analysis. Front Aging Neurosci 17:1582579. https:\/\/doi.org\/10.3389\/fnagi.2025.1582579","journal-title":"Front Aging Neurosci"},{"key":"2386_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550893","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Wang Y, Yang L, Zhang Y, Yang L (2025b) TREM2+ macrophages: a key role in disease development. Front Immunol 16:p.1550893. https:\/\/doi.org\/10.3389\/fimmu.2025.1550893","journal-title":"Front Immunol"},{"key":"2386_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114426","author":"G Wang","year":"2025","unstructured":"Wang G, Wang N, Xia X, Ismail M, Shi B (2025c) Clinical translation of nanomedicines for brain diseases: current challenges and future directions. J Control Release. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114426","journal-title":"J Control Release"},{"key":"2386_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1591438","volume":"16","author":"K Wang","year":"2025","unstructured":"Wang K, Yang R, Li J, Wang H, Wan L, He J (2025d) Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation. Front Pharmacol 16:1591438. https:\/\/doi.org\/10.3389\/fphar.2025.1591438","journal-title":"Front Pharmacol"},{"issue":"1","key":"2386_CR218","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40364-026-00895-2","volume":"14","author":"Z Wang","year":"2026","unstructured":"Wang Z, Cheng G, Guo W, Chen H, Zhou Z, Shi R, Gao H, Li H, Tu J, Chen W, Yang S (2026a) Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions. Biomark Res 14(1):36. https:\/\/doi.org\/10.1186\/s40364-026-00895-2","journal-title":"Biomark Res"},{"issue":"1","key":"2386_CR219","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s40820-026-02205-9","volume":"18","author":"Z Wang","year":"2026","unstructured":"Wang Z, Liu Z, Song L, Zhao X, Feng S, Di D, Ju H, Wan L, Zhao Q (2026b) Advances in polydopamine-based nanoplatforms: antioxidant mechanisms and applications in oxidative stress-mediated diseases. Nano-Micro Lett 18(1):372. https:\/\/doi.org\/10.1007\/s40820-026-02205-9","journal-title":"Nano-Micro Lett"},{"key":"2386_CR220","doi-asserted-by":"publisher","DOI":"10.7150\/thno.57510","author":"KT Xenaki","year":"2021","unstructured":"Xenaki KT, Dorresteijn B, Muns JA, Adamzek K, Doulkeridou S, Houthoff H, Oliveira S, En Henegouwen PMVB (2021) Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice. Theranostics. https:\/\/doi.org\/10.7150\/thno.57510","journal-title":"Theranostics"},{"key":"2386_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102572","author":"X Xia","year":"2025","unstructured":"Xia X, Liu X, Gao Y, Lin J, Pan S, Cheng W, Huang S, Liu X, Shen JW, Duan W (2025) Engineered metallic hybrid nanozyme for advanced inflammatory disease therapy. Mater Today Bio. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102572","journal-title":"Mater Today Bio"},{"issue":"2","key":"2386_CR222","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J (2023) Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7 FAD mice. Nat Aging 3(2):202\u2013212. https:\/\/doi.org\/10.1038\/s43587-022-00337-2","journal-title":"Nat Aging"},{"issue":"4","key":"2386_CR223","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R (2025a) NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol 22(4):341\u2013355. https:\/\/doi.org\/10.1038\/s41423-025-01275-w","journal-title":"Cell Mol Immunol"},{"key":"2386_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123812","volume":"378","author":"C Xu","year":"2025","unstructured":"Xu C, Zhu R, Dai Q, Xu G, Zhang G (2025b) The role and mechanism of the NLRP3-IL-1\u03b2\/IL-18 signaling axis in the progression of sepsis under an aging phenotype. Life Sci 378:123812. https:\/\/doi.org\/10.1016\/j.lfs.2025.123812","journal-title":"Life Sci"},{"issue":"1","key":"2386_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14373","volume":"21","author":"J Xu","year":"2025","unstructured":"Xu J, Song W, Xu Z, Danziger MM, Karavani E, Zang C, Chen X, Li Y, Paz IMR, Gohel D, Su C (2025c) Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer\u2019s disease. Alzheimers Dement 21(1):e14373. https:\/\/doi.org\/10.1002\/alz.14373","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2386_CR226","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12927","volume":"41","author":"L Xue","year":"2025","unstructured":"Xue L, Wu YY (2025) Activation of PPAR\u03b3 regulates M1\/M2 macrophage polarization and attenuates dextran sulfate sodium salt\u2010induced inflammatory bowel disease via the STAT\u20101\/STAT\u20106 pathway. Kaohsiung J Med Sci 41(2):p.e12927. https:\/\/doi.org\/10.1002\/kjm2.12927","journal-title":"Kaohsiung J Med Sci"},{"key":"2386_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1535682","volume":"12","author":"VK Yadav","year":"2025","unstructured":"Yadav VK, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R, Pramanik S, Kumar P, Gupta N, Patel A (2025) Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives. Front Med 12:1535682. https:\/\/doi.org\/10.3389\/fmed.2025.1535682","journal-title":"Front Med"},{"issue":"8","key":"2386_CR228","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"HM Yang","year":"2025","unstructured":"Yang HM (2025) Overcoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases. Pharmaceutics 17(8):1041. https:\/\/doi.org\/10.3390\/pharmaceutics17081041","journal-title":"Pharmaceutics"},{"issue":"7816","key":"2386_CR229","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang AC, Stevens MY, Chen MB, Lee DP, St\u00e4hli D, Gate D, Contrepois K, Chen W, Iram T, Zhang L, Vest RT (2020) Physiological blood\u2013brain transport is impaired with age by a shift in transcytosis. Nature 583(7816):425\u2013430. https:\/\/doi.org\/10.1038\/s41586-020-2453-z","journal-title":"Nature"},{"key":"2386_CR230","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3389\/fneur.2023.1149618","volume":"21","author":"D Yang","year":"2023","unstructured":"Yang D, Wang Z, Chen Y, Guo Q, Dong Y (2023) Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis. Comput Struct Biotechnol J 21:2215\u20132227. https:\/\/doi.org\/10.3389\/fneur.2023.1149618","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"2386_CR231","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/13872877241313223","volume":"104","author":"X Yang","year":"2025","unstructured":"Yang X, Wang J, Jia X, Yang Y, Fang Y, Ying X, Li H, Zhang M, Wei J, Pan Y (2025a) Microglial polarization in Alzheimer\u2019s disease: mechanisms, implications, and therapeutic opportunities. J Alzheimers Dis 104(1):3\u201313. https:\/\/doi.org\/10.1177\/13872877241313223","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"2386_CR232","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2174\/011570159X350611250303044527","volume":"23","author":"Q Yang","year":"2025","unstructured":"Yang Q, Qiu Y, Ni J, Li H, Qing H (2025b) Deciphering T cell dynamics in Alzheimer\u2019s disease pathogenesis: insights and implications. Curr Neuropharmacol 23(12):1533. https:\/\/doi.org\/10.2174\/011570159X350611250303044527","journal-title":"Curr Neuropharmacol"},{"key":"2386_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114083","volume":"181","author":"MA Younis","year":"2022","unstructured":"Younis MA, Tawfeek HM, Abdellatif AA, Abdel-Aleem JA, Harashima H (2022) Clinical translation of nanomedicines: challenges, opportunities, and keys. Adv Drug Deliv Rev 181:p.114083. https:\/\/doi.org\/10.1016\/j.addr.2021.114083","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2386_CR234","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41419-025-07945-x","volume":"16","author":"B Yuan","year":"2025","unstructured":"Yuan B, Zhang X, Liu L, Chai Y, Zhang J, Chen X (2025) Neutrophils-astrocyte interactions in central nervous system inflammation. Cell Death Dis 16(1):643. https:\/\/doi.org\/10.1038\/s41419-025-07945-x","journal-title":"Cell Death Dis"},{"issue":"10","key":"2386_CR235","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12(10):1416. https:\/\/doi.org\/10.3390\/cells12101416","journal-title":"Cells"},{"key":"2386_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116897","author":"S Zeng","year":"2026","unstructured":"Zeng S, Zhang S, Gui X, Li D, Lv S, Dong H, Xu Q, Wu J, Ren H, Zhao Q, Long H (2026) A monoclonal antibody targeting the C-terminal of \u03b1-synuclein fibrils mitigates pathology in a Parkinson\u2019s disease model. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2025.116897","journal-title":"Cell Rep"},{"issue":"3","key":"2386_CR237","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong KL, All AH (2024) Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano 18(3):1820. https:\/\/doi.org\/10.1021\/acsnano.3c10674","journal-title":"ACS Nano"},{"issue":"12","key":"2386_CR238","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang H, Zhao F, Jiang Z, Cui Y, Ou M, Mei L, Wang Q (2023a) Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment. Acta Pharm Sin B 13(12):5107\u20135120. https:\/\/doi.org\/10.1016\/j.apsb.2023.06.011","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"2386_CR239","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/acs.bioconjchem.3c00266","volume":"34","author":"C Zhang","year":"2023","unstructured":"Zhang C, Jiang G, Gao X (2023b) Matrix metalloproteinase-responsive drug delivery systems. Bioconjug Chem 34(8):1349\u20131365. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00266","journal-title":"Bioconjug Chem"},{"issue":"1","key":"2386_CR240","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023c) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"2386_CR241","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1659216","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang H, He Z, Yin C, Yang S, Li J, Lin H, Hu G, Wu A, Qin D, Hu G, Yu L (2025a) STING-mediated neuroinflammation: a therapeutic target in neurodegenerative diseases. Front Aging Neurosci 17:1659216. https:\/\/doi.org\/10.3389\/fnagi.2025.1659216","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2386_CR242","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-025-00812-5","volume":"20","author":"S Zhang","year":"2025","unstructured":"Zhang S, Gao Y, Zhao Y, Huang TY, Zheng Q, Wang X (2025b) Peripheral and central neuroimmune mechanisms in Alzheimer\u2019s disease pathogenesis. Mol Neurodegener 20(1):22. https:\/\/doi.org\/10.1186\/s13024-025-00812-5","journal-title":"Mol Neurodegener"},{"issue":"12","key":"2386_CR243","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70548","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Z, Guan H, Qiu Z, Zou C (2025c) Engineering exosomes for Alzheimer\u2019s disease: multi-target therapeutic strategies from pathogenesis to clinical translation. Clin Transl Med 15(12):e70548. https:\/\/doi.org\/10.1002\/ctm2.70548","journal-title":"Clin Transl Med"},{"key":"2386_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125202","volume":"671","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chan HW, Shao Z, Wang Q, Chow S, Chow SF (2025d) Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing. Int J Pharm 671:125202. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125202","journal-title":"Int J Pharm"},{"issue":"1","key":"2386_CR245","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2580730","volume":"32","author":"X Zhao","year":"2025","unstructured":"Zhao X, Xu Z, Wang D, Li T, Xu L, Li Z, Bai X, Zhu H, Liu Y, Wang Y (2025b) Nanotechnology-based targeted regulation of NLRP3 inflammasome: therapeutic strategies and clinical application prospects in inflammatory diseases. Drug Deliv 32(1):p.2580730. https:\/\/doi.org\/10.1080\/10717544.2025.2580730","journal-title":"Drug Deliv"},{"key":"2386_CR246","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-07748-4","author":"K Zhao","year":"2026","unstructured":"Zhao K, Cui S, Wang N, Wei Q, Wang X, Hou K, Zhu J, Kong F (2026) The cGAS-STING pathway and mitochondrial metabolism: from mechanistic insights to therapeutic potential in tumor. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-026-07748-4","journal-title":"J Transl Med"},{"key":"2386_CR247","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.1008681","author":"L Zhao","year":"2025","unstructured":"Zhao L, Peng T, Wu SY (2025a) Iron Oxide Nanoparticles Application in Toxicity Therapeutics of CNS Disorders Indicated by Molecular MRI. In Recent Progress and Development in Nanostructures. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.1008681","journal-title":"IntechOpen"},{"key":"2386_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978513","volume":"13","author":"F Zheng","year":"2022","unstructured":"Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G (2022) Applications of nanobodies in brain diseases. Front Immunol 13:978513. https:\/\/doi.org\/10.3389\/fimmu.2022.978513","journal-title":"Front Immunol"},{"issue":"11","key":"2386_CR249","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400459","volume":"357","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhang X, Wang Z, Zhang R, Wei H, Yan X, Jiang X, Yang L (2024) MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: a review of preclinical research and future directions. Arch Pharm 357(11):e2400459. https:\/\/doi.org\/10.1002\/ardp.202400459","journal-title":"Arch Pharm"},{"key":"2386_CR250","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2026.1764964","volume":"20","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Zhou W, Chang H, Zheng K (2026) Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery. Front Neurosci 20:1764964. https:\/\/doi.org\/10.3389\/fnins.2026.1764964","journal-title":"Front Neurosci"},{"issue":"7329","key":"2386_CR251","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469(7329):221\u2013225. https:\/\/doi.org\/10.1038\/nature09663","journal-title":"Nature"},{"key":"2386_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114679","volume":"156","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Luo J, Chai X, Yang J, Zhong S, Zhang Z, Chang X, Wang H (2025) Therapeutic targeting the cGAS\u2212 STING pathway associated with protein and gene: an emerging and promising novel strategy for aging-related neurodegenerative disease. Int Immunopharmacol 156:114679. https:\/\/doi.org\/10.1016\/j.intimp.2025.114679","journal-title":"Int Immunopharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02386-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:15Z","timestamp":1792194915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02386-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":252,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02386-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has no conflict of interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author affirms that the manuscript represents the author's original work and analysis. AI-based tools were used only to assist with language refinement and clarity. All scientific content, interpretations, figures, tables, and references were developed, verified, and written solely by the author. The author takes full responsibility for the accuracy, completeness, and integrity of the work.","order":2,"name":"Ethics","label":"Declaration of AI use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}